Today: 7 February 2026
Subscribe
Browse Category

NYSE:SMR News 28 December 2025 - 29 January 2026

Oklo stock price drops 9% as nuclear trade cools; DOE deadline is the next tell

Oklo stock price drops 9% as nuclear trade cools; DOE deadline is the next tell

Oklo Inc shares fell 9.3% to $85.59 Thursday, reversing gains after a surge on a new Buy rating and $138 price target from Texas Capital Securities. The drop hit peers, with NuScale Power down 8%. Oklo recently finalized a land deal with Meta for a 1.2-gigawatt nuclear campus in Ohio. The Energy Department on Wednesday sought state input on sites for “Nuclear Lifecycle Innovation Campuses.”
29 January 2026
·····
Centrus Energy (LEU) stock price jumps into long weekend as nuclear fuel trade stays in focus

Centrus Energy (LEU) stock price jumps into long weekend as nuclear fuel trade stays in focus

Centrus Energy shares surged 8.2% to $331.03 Friday, with trading volume near 1.6 million, after the U.S. signed a civil nuclear deal with Slovakia and investors focused on government-backed reactor plans. Cameco rose 3.2%, BWX Technologies 2.2%, and NuScale Power 7.0%. Centrus recently secured a $900 million Department of Energy contract to expand uranium enrichment in Ohio. U.S. markets reopen Tuesday.
17 January 2026
······
NuScale Power stock jumps as Washington’s AI power plan puts new reactors back in play

NuScale Power stock jumps as Washington’s AI power plan puts new reactors back in play

NuScale Power shares climbed about 6% to $20.03 by midday Friday, leading U.S. power stocks after White House efforts to shift more grid costs to data center operators. PJM grid states prepared to sign a two-year price cap deal at the White House, sources said. Traders watched for possible PJM auction changes affecting nuclear project economics. Volume in NuScale topped 20 million shares by early afternoon.
16 January 2026
·······
Oklo stock jumps again in premarket as Meta nuclear deal keeps OKLO in focus

Oklo stock jumps again in premarket as Meta nuclear deal keeps OKLO in focus

Oklo shares rose 7.9% to $105.31 in early premarket trading Monday after Meta announced 20-year nuclear power deals, including a collaboration with Oklo on small modular reactors. Oklo confirmed Meta will prepay for power and help fund a 1.2-gigawatt project in Ohio. Vistra and NuScale Power also gained before the bell. Regulatory hurdles and insider selling remain in focus.
12 January 2026
····
NuScale Power stock set for Monday test after BofA upgrade keeps SMR trade alive

NuScale Power stock set for Monday test after BofA upgrade keeps SMR trade alive

NuScale Power shares closed at $20.51 Friday, up 4.3% amid sector gains and volatility. Bank of America upgraded the stock to Neutral but cut its price target to $28, citing a “screening year” ahead. Meta Platforms signed 20-year nuclear power deals, boosting investor sentiment across the sector. NuScale continues to seek permits and customers for its small modular reactor projects.
12 January 2026
····
NuScale Power stock pops on BofA upgrade as Meta’s nuclear push puts SMR names back in play

NuScale Power stock pops on BofA upgrade as Meta’s nuclear push puts SMR names back in play

NuScale Power shares rose 4.4% to $20.51 Friday after Bank of America upgraded the stock to neutral and cut its price target to $28. The move followed Meta’s announcement of major nuclear power contracts for its data centers, which lifted several nuclear-related stocks. About 51 million NuScale shares traded hands. U.S. markets reopen Monday.
11 January 2026
······
NuScale Power stock pops on BofA upgrade as Meta’s nuclear push lifts the SMR trade

NuScale Power stock pops on BofA upgrade as Meta’s nuclear push lifts the SMR trade

NuScale Power shares closed up 4.3% at $20.51 Friday after Bank of America upgraded the stock. The move followed Meta’s announcement of 20-year nuclear power deals and plans to support small modular reactor development. NuScale remains below key moving averages and faces dilution risk from a $750 million at-the-market offering. Next earnings update is expected in early March.
10 January 2026
····
NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

NuScale Power stock jumps after Bank of America upgrade as Meta nuclear pacts lift SMR trade

NuScale Power shares rose 4.3% to $20.51 in after-hours trading Friday after Bank of America upgraded the stock to neutral with a $28 target, citing funding and timing challenges. Meta’s new nuclear power deals fueled sector-wide gains, with Vistra and Oklo jumping nearly 14%. Options trading in NuScale surged 31% above average. The stock remains below key moving averages ahead of earnings expected March 2.
10 January 2026
····
Vistra stock jumps after Meta signs 20-year nuclear power deal — what’s driving VST today

Vistra stock jumps after Meta signs 20-year nuclear power deal — what’s driving VST today

Vistra Corp shares jumped 11.4% to $167.81 after announcing 20-year nuclear power purchase agreements with Meta Platforms covering over 2,600 MW from three plants. The contracts begin deliveries in late 2026 and could boost Vistra’s adjusted free cash flow by up to 17% once fully in place. Meta also signed nuclear deals with two other firms. Vistra stock remains below its September high of $219.82.
9 January 2026
······
NuScale Power stock jumps in premarket after BofA upgrade lifts SMR shares

NuScale Power stock jumps in premarket after BofA upgrade lifts SMR shares

NuScale Power shares rose about 12% to $22.08 in premarket trading Friday after Bank of America Securities upgraded the stock to “Neutral” from “Underperform.” The bank cited a 60% price correction and ongoing funding and dilution risks, while cutting its price target to $28. NuScale remains below its 200-day moving average. The December U.S. jobs report is due at 8:30 a.m. ET.
9 January 2026
··
NuScale Power stock slips as Capitol Hill nuclear hearing puts SMR trade back in play

NuScale Power stock slips as Capitol Hill nuclear hearing puts SMR trade back in play

NuScale Power shares fell 1.6% to $19.25 Wednesday morning on volume over 7 million, as investors watched a House hearing on nuclear licensing set for 10:15 a.m. ET. The move followed new U.S. Energy Department contracts for domestic uranium enrichment. Broader markets edged higher, while nuclear stocks were mixed. NuScale is seeking customer deals and financing after canceling its Carbon Free Power Project last year.
7 January 2026
··
Oklo stock jumps toward $100 as DOE’s $2.7 billion uranium move lifts nuclear plays

Oklo stock jumps toward $100 as DOE’s $2.7 billion uranium move lifts nuclear plays

New York, January 6, 2026, 18:51 EST — After-hours Oklo Inc. shares rose about 7% to $95.60 in after-hours trading on Tuesday, pushing closer to the $100 level traders often watch. The stock traded as high as $96.82 earlier in the session, with about 20 million shares changing hands. The move came as investors continued to price in fresh U.S. support for the nuclear fuel supply chain. The U.S. Department of Energy said it awarded $2.7 billion in task orders to American Centrifuge Operating, General Matter and Orano Federal Services to expand enrichment services for low-enriched uranium and high-assay low-enriched
7 January 2026
····
NuScale stock extends rally as U.S. nuclear-fuel push lifts sector; House hearing ahead

NuScale stock extends rally as U.S. nuclear-fuel push lifts sector; House hearing ahead

New York, Jan 6, 2026, 0947 EST — Regular session Key points: NuScale Power shares were up 4.7% at $19.67 in morning trade on Tuesday, after jumping 15.1% in the previous session as traders piled back into nuclear-related names. The latest leg higher followed a U.S. push to shore up the nuclear fuel supply chain. The Energy Department said on Monday it awarded orders totaling $2.7 billion to three companies to expand domestic uranium enrichment over the next decade, including high-assay low-enriched uranium, or HALEU, a fuel needed for some advanced reactor designs. Energy Secretary Chris Wright said the awards
6 January 2026
·
Oklo stock jumps nearly 15% as DOE backs uranium enrichment — what’s next for OKLO

Oklo stock jumps nearly 15% as DOE backs uranium enrichment — what’s next for OKLO

New York, January 5, 2026, 19:30 EST — After-hours Oklo Inc. shares rose 14.8% on Monday and were little changed in after-hours trading, as investors piled into advanced nuclear names after the U.S. Energy Department moved to expand domestic uranium enrichment. The stock closed at $89.34. The federal awards target high-assay low-enriched uranium, or HALEU — fuel enriched beyond the level used in most of today’s reactors — as well as standard low-enriched uranium, the department said. HALEU is uranium enriched between 5% and 20%, compared with about 5% for conventional reactor fuel. (Reuters) Why it matters now: fuel supply
6 January 2026
····
NuScale Power (SMR) stock jumps 13% today as nuclear shares rally — what’s driving the move

NuScale Power (SMR) stock jumps 13% today as nuclear shares rally — what’s driving the move

NEW YORK, Jan 2, 2026, 1:04 PM ET — Regular session Shares of NuScale Power Corp (NYSE:SMR) climbed on Friday, lifting the nuclear technology stock early in the first session of 2026. The shares were up 13.2% at $16.05, after touching $16.07, with about 17.6 million shares traded. The move matters because NuScale sits in a pocket of the market where flows can dominate fundamentals for long stretches. Investors treat small modular reactor developers as a long-duration bet on future electricity demand, making the stocks sensitive to shifts in risk appetite. Friday’s jump also stood out against a mixed tape,
2 January 2026
··
Oklo stock ends 2025 near $72: what’s driving OKLO and what investors watch next

Oklo stock ends 2025 near $72: what’s driving OKLO and what investors watch next

NEW YORK, December 31, 2025, 21:05 ET — Market closed Oklo Inc. shares were last up about 0.2% at $71.76 on Wednesday after the U.S. market close, capping a muted year-end session for the nuclear start-up. The near-flat finish matters because Oklo’s stock has been driven less by current earnings and more by expectations for when it can license and deploy its first reactors. That puts investors’ attention on regulatory timelines and how the company funds its buildout. Oklo+1 Oklo is developing what it calls the Aurora “powerhouse,” part of a wave of so-called small modular reactors (SMRs) — smaller
1 January 2026
····
Oklo stock slips 3% at the close as insiders reshuffle holdings; what traders watch next

Oklo stock slips 3% at the close as insiders reshuffle holdings; what traders watch next

NEW YORK, December 30, 2025, 21:24 ET — Market closed. Oklo Inc. shares fell 3.3% on Tuesday to end at $71.62, lagging the broader market in the year’s final trading week. The slide matters now because liquidity is thin into year-end, and price swings can get sharper in high-volatility stocks when fewer investors are active. Oklo, which says it is a fission technology and nuclear fuel recycling company, has traded as a high-beta nuclear-power bet, leaving it sensitive to shifts in risk appetite and any signal on funding or regulatory timelines. Oklo On Wall Street, the S&P 500 and Nasdaq
31 December 2025
····
NuScale stock slides as dilution fears linger ahead of Monday’s open

NuScale stock slides as dilution fears linger ahead of Monday’s open

NEW YORK, December 29, 2025, 03:22 ET — Market closed NuScale Power Corporation shares closed down 7.7% on Friday at $14.85, extending a slide that has kept investors focused on potential dilution from future share issuance. The move comes after NuScale disclosed that stockholders approved an amendment to double the company’s authorized Class A common shares to 662 million from 332 million at a Dec. 16 special meeting. SEC Authorized shares are the maximum number of shares a company is allowed to issue under its charter. Investors often watch authorized-share increases because they can pave the way for new stock
29 December 2025
··
NuScale Power Corporation Stock (SMR) Slides Into Year-End: Dilution Fears, Analyst Targets, and What to Watch Before Monday’s Open

NuScale Power Corporation Stock (SMR) Slides Into Year-End: Dilution Fears, Analyst Targets, and What to Watch Before Monday’s Open

NEW YORK, Dec. 28, 2025, 4:28 a.m. ET — Market closed (Weekend). NuScale Power Corporation (NYSE: SMR) is heading into the final trading days of 2025 under a cloud of renewed volatility after a sharp selloff in Friday’s session. Shares were last indicated around $14.85 in the most recent available prints, following a steep decline from the prior close and unusually heavy turnover for the name. MarketBeat+1 With U.S. stock markets closed for the weekend, investors now have time to digest what drove the move—and what could matter most when trading resumes Monday, Dec. 29. The immediate storyline centers on
28 December 2025
·
1 2

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop